TREM2, which is genetically implicated in AD, interacts with CD33 (another AD susceptibility gene)35, is an important contributor in the clearance of toxic Amyloid-β by microglia in mice36, and is correlated with Aβ deposition in the human brain35. This evidence concerns the gene CD33 and Alzheimer disease.